Terms: = Liver cancer AND NCOR1, hCIT529I10, 9611, ENSG00000141027, N-CoR, MGC104216, TRAC1, O75376, hN-CoR, KIAA1047
18 results:
1. Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinoma.
Kaya NA; Tai D; Lim X; Lim JQ; Lau MC; Goh D; Phua CZJ; Wee FYT; Joseph CR; Lim JCT; Neo ZW; Ye J; Cheung L; Lee J; Loke KSH; Gogna A; Yao F; Lee MY; Shuen TWH; Toh HC; Hilmer A; Chan YS; Lim TK; Tam WL; Choo SP; Yeong J; Zhai W
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586766
[TBL] [Abstract] [Full Text] [Related]
2. Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis.
Qureshi R; Picon-Ruiz M; Sho M; Van Booven D; Nunes de Paiva V; Diaz-Ruano AB; Ince TA; Slingerland J
Cell Rep; 2022 Nov; 41(7):111672. PubMed ID: 36384125
[TBL] [Abstract] [Full Text] [Related]
3. Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria.
Sun X; Li L; Xu L; Zhou Z; Chen J; Wang J; Zhang Y; Hu D; Chen M
BMC Cancer; 2021 Feb; 21(1):147. PubMed ID: 33563246
[TBL] [Abstract] [Full Text] [Related]
4. Integrated Bioinformatics Analysis of the Clinical Value and Biological Function of ATAD2 in Hepatocellular Carcinoma.
Meng X; Wang L; Zhu B; Zhang J; Guo S; Li Q; Zhang T; Zheng Z; Wu G; Zhao Y
Biomed Res Int; 2020; 2020():8657468. PubMed ID: 32462022
[TBL] [Abstract] [Full Text] [Related]
5. Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma.
Jiang D; Deng J; Dong C; Ma X; Xiao Q; Zhou B; Yang C; Wei L; Conran C; Zheng SL; Ng IO; Yu L; Xu J; Sham PC; Qi X; Hou J; Ji Y; Cao G; Li M
BMC Cancer; 2020 May; 20(1):403. PubMed ID: 32393195
[TBL] [Abstract] [Full Text] [Related]
6. cancerliver: a database of liver cancer gene expression resources and biomarkers.
Kaur H; Bhalla S; Kaur D; Raghava GP
Database (Oxford); 2020 Jan; 2020():. PubMed ID: 32147717
[TBL] [Abstract] [Full Text] [Related]
7. ER-Negative Breast cancer Is Highly Responsive to Cholesterol Metabolite Signalling.
Hutchinson SA; Lianto P; Roberg-Larsen H; Battaglia S; Hughes TA; Thorne JL
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31683867
[TBL] [Abstract] [Full Text] [Related]
8. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
9. Identification of novel blood-based HCC-specific diagnostic biomarkers for human hepatocellular carcinoma.
Yin L; He N; Chen C; Zhang N; Lin Y; Xia Q
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1908-1916. PubMed ID: 31072138
[TBL] [Abstract] [Full Text] [Related]
10. Gene Signature Associated with Upregulation of the Wnt/β-Catenin Signaling Pathway Predicts Tumor Response to Transarterial Embolization.
Ziv E; Yarmohammadi H; Boas FE; Petre EN; Brown KT; Solomon SB; Solit D; Reidy D; Erinjeri JP
J Vasc Interv Radiol; 2017 Mar; 28(3):349-355.e1. PubMed ID: 28126478
[TBL] [Abstract] [Full Text] [Related]
11. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
Fujimoto A; Furuta M; Totoki Y; Tsunoda T; Kato M; Shiraishi Y; Tanaka H; Taniguchi H; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Wardell CP; Hayami S; Nakamura T; Aikata H; Arihiro K; Boroevich KA; Abe T; Nakano K; Maejima K; Sasaki-Oku A; Ohsawa A; Shibuya T; Nakamura H; Hama N; Hosoda F; Arai Y; Ohashi S; Urushidate T; Nagae G; Yamamoto S; Ueda H; Tatsuno K; Ojima H; Hiraoka N; Okusaka T; Kubo M; Marubashi S; Yamada T; Hirano S; Yamamoto M; Ohdan H; Shimada K; Ishikawa O; Yamaue H; Chayama K; Miyano S; Aburatani H; Shibata T; Nakagawa H
Nat Genet; 2016 May; 48(5):500-9. PubMed ID: 27064257
[TBL] [Abstract] [Full Text] [Related]
12. Colorectal cancer Genetic Heterogeneity Delineated by Multi-Region Sequencing.
Lu YW; Zhang HF; Liang R; Xie ZR; Luo HY; Zeng YJ; Xu Y; Wang LM; Kong XY; Wang KH
PLoS One; 2016; 11(3):e0152673. PubMed ID: 27023146
[TBL] [Abstract] [Full Text] [Related]
13. PPARs and ERRs: molecular mediators of mitochondrial metabolism.
Fan W; Evans R
Curr Opin Cell Biol; 2015 Apr; 33():49-54. PubMed ID: 25486445
[TBL] [Abstract] [Full Text] [Related]
14. Meta-analysis of the association between a polymorphism in microRNA-196a2 and susceptibility to colorectal cancer.
Shi KQ; Lin Z; Li DW; Fang YX; Gao J; Deng ZJ; Chen L; Li GL; Wu JM; Tang KF
Onkologie; 2013; 36(10):560-5. PubMed ID: 24107909
[TBL] [Abstract] [Full Text] [Related]
15. Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells.
Song K; Han C; Zhang J; Lu D; Dash S; Feitelson M; Lim K; Wu T
Hepatology; 2013 Nov; 58(5):1681-92. PubMed ID: 23703729
[TBL] [Abstract] [Full Text] [Related]
16. Differential recruitment of nuclear coregulators directs the isoform-dependent action of mutant thyroid hormone receptors.
Fozzatti L; Lu C; Kim DW; Cheng SY
Mol Endocrinol; 2011 Jun; 25(6):908-21. PubMed ID: 21474540
[TBL] [Abstract] [Full Text] [Related]
17. Hdac3 is essential for the maintenance of chromatin structure and genome stability.
Bhaskara S; Knutson SK; Jiang G; Chandrasekharan MB; Wilson AJ; Zheng S; Yenamandra A; Locke K; Yuan JL; Bonine-Summers AR; Wells CE; Kaiser JF; Washington MK; Zhao Z; Wagner FF; Sun ZW; Xia F; Holson EB; Khabele D; Hiebert SW
Cancer Cell; 2010 Nov; 18(5):436-47. PubMed ID: 21075309
[TBL] [Abstract] [Full Text] [Related]
18. Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs.
Chan IH; Privalsky ML
Oncogene; 2006 Jun; 25(25):3576-88. PubMed ID: 16434963
[TBL] [Abstract] [Full Text] [Related]
